Gilead acquires biotechnology company Ouro for up to $2.2 billion
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
```htmlGolden Ten Data, March 24|Gilead Sciences announced that it has signed a definitive agreement to acquire Ouro Medicines, a privately held biotechnology company focused on developing therapies for autoimmune diseases. Gilead will pay a $1.675 billion upfront cash consideration (subject to customary adjustments), plus up to $500 million in potential milestone payments. This transaction adds OM336 (gamgertamig) to Gilead’s inflammation portfolio, a BCMAxCD3 T cell engager currently in clinical development. In ongoing phase 1/2 clinical studies, the drug has demonstrated efficacy in severe autoimmune diseases, including autoimmune hemolytic anemia and immune thrombocytopenia. OM336 has received Fast Track and Orphan Drug designations.```
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Australia advances tokenized asset market infrastructure development
Chaincatcher•2026/03/26 00:16
Polymarket Bids Farewell to Zero-Fee Era, Introduces Taker Fees on Almost All Trades
BlockBeats•2026/03/26 00:11
Futures Hotspot Tracking
金十•2026/03/26 00:11
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$71,198.5
+0.70%
Ethereum
ETH
$2,164.93
+0.34%
Tether USDt
USDT
$0.9997
+0.00%
BNB
BNB
$647.07
+1.13%
XRP
XRP
$1.41
-0.42%
USDC
USDC
$1.0000
-0.00%
Solana
SOL
$91.56
+0.48%
TRON
TRX
$0.3136
+2.61%
Dogecoin
DOGE
$0.09602
+0.79%
Hyperliquid
HYPE
$40.17
-0.69%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now